Lighthouse Biosciences to develop device for MRSA detection

Rochester, N.Y.-based Lighthouse Biosciences LLC plans to develop prototypes of its device equipped with interchangeable chips that could help detect methicillin-resistant Staphylococcus aureus infections in anywhere from 15 minutes to two or three hours. The NanoLantern process can identify infectious agents by searching for the DNA's segment found in certain pathogens.

View Full Article in:

Rochester Democrat and Chronicle (N.Y.) (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY